Flexible tools for single cell analysis
Scribe Biosciences's investors include National Science Foundation, Casdin Capital, Harmonix Fund, BioTools Innovator, Formic Ventures.
Scribe Biosciences is headquartered in San Francisco, United States.
Flexible tools for single cell analysis
Scribe Biosciences is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scribe Biosciences — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/scribe-biosciences. Accessed September 30, 2026.
VCBacked. (2023). Scribe Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/scribe-biosciences
{{cite web |title=Scribe Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/scribe-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated